longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

LDOS

LDOS
----

LongbridgeAI

Weekly Recap | Leidos -0.91%, consensus target above spot

Weekly Review
Sep 19, 2026 at 06:17 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Leidos fell 0.91% this week, closing at $127.69. The S&P 500 slipped 0.08%, so the stock underperformed by roughly 0.83 percentage point. The daily bars show a fade after an early spike: Monday (Sep 14) pushed up to a high of $133.91 and closed at $132.83, Tuesday (Sep 15) traded as high as $133.925 before pulling back, and Friday (Sep 18) slid to $127.25 to finish near the week’s low. Trading volume across the week came in above the recent median.

The Week

Leidos fell 0.91% this week, closing at $127.69. The S&P 500 slipped 0.08%, so the stock underperformed by roughly 0.83 percentage point. The daily bars show a fade after an early spike: Monday (Sep 14) pushed up to a high of $133.91 and closed at $132.83, Tuesday (Sep 15) traded as high as $133.925 before pulling back, and Friday (Sep 18) slid to $127.25 to finish near the week’s low. Trading volume across the week came in above the recent median.

Key Events

The most concrete company development came on Saturday, Sep 19, when Leidos was reported to have won an $85 million U.S. Air Force contract. That news landed after the trading week ended, so it was not reflected in the five sessions covered here. Midweek reports painted a mixed picture on relative strength: a Wednesday item noted the stock underperformed peers on Tuesday, while a Friday item described a strong trading day that outperformed competitors. On Tuesday, Leidos also appeared alongside AstraZeneca and Expeditors in market commentary, though that was more about sentiment than any company-specific catalyst.

Analyst Ratings

Leidos is covered by 17 analysts: 4 rate it buy, 3 overweight, and 10 hold. There are no underweight or sell ratings. The consensus recommendation is buy, and the consensus target price is $157.27, roughly 23.2% above the latest close. Targets range from $132 to $225, a wide spread that points to real disagreement on valuation. Within the research and consulting services industry, Leidos ranks 5th out of 40 companies in analyst rating consensus.

The Week Ahead

Next week’s macro calendar runs from Tuesday to Thursday. Sep 22 brings the Richmond Fed composite index, Sep 23 brings EIA weekly crude oil and Cushing crude inventory data, and Sep 24 brings jobless claims, the current account balance, new home sales annual rate, and EIA natural gas inventory changes. Leidos itself has no scheduled earnings or company events, so the stock is likely to track broader U.S. macro data and defence-sector sentiment.

In Short

The key tension this week sits between a broadly constructive analyst picture and a stock that faded after an early spike. The consensus target price is more than 20% above spot, with most ratings clustered in buy and hold, yet the shares closed lower and lagged the index. Large-lot money was a net buyer in the latest session while medium and small-lot flows sold. The weekend Air Force contract is a concrete item to watch, but the market has not yet had a chance to price it.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.

Login to unlock2,136characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Leidos

Leidos

LDOS.US

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--